210) erapies to combat this hyper-inflammatory response. |
211) ironments to regulate the cellular immune response. |
212) ationship between maternal PA and myokine response. |
213) -remains central to a successful pandemic response. |
214) itigated neutrophil mediated inflammatory response. |
215) Aergic biomarker associated with ketamine response. |
216) by naltrexone may be related to clinical response. |
217) eam signaling cascade of unfolded protein response. |
218) in human disease and drug disposition and response. |
219) inds G3BP2 and interferes with the stress response. |
220) ve as a potential predictor for tamoxifen response. |
221) ed immune cell correlates of chemotherapy response. |
222) meaningful biomarker of the conditioning response. |
223) hways involved in DNA damage and cellular response. |
224) lity, parenchyma surveillance, and injury response. |
225) a pro-tumorigenic development antioxidant response. |
226) lence factors provokes a secondary immune response1. |
227) d to play an important role in the immune response and BRD pathogenesis. |
228) though the mechanisms underpinning the HS response and CWI cross talking are not elu |
229) ue to the underlying host's immunological response and are not specific to the patho |
230) rves as a crucial link between the immune response and cancer. |
231) Ibrutinib reduced cocaine-induced startle response and cocaine-induced seizures (n |
232) Attribution of the immune response and consequent clinical outcomes |
233) Treatment response and disease-specific prognosis we |
234) r companies and determined that induction response and drug-drug risk assessment det |
235) se the most recent data regarding vaccine response and efficacy in this setting, par |
236) ology (electronic referral, coordination, response and feedback), processes (effecti |
237) re affected included the unfolded protein response and immune/defense responses. |
238) nd several enzymes associated with immune response and metabolism. |
239) APP/PS1 mice, including the immune system response and neurotransmission, represent |
240) of less intensive therapy to consolidate response and prevent relapses. |
241) shows an excellent sensing response, fast response and recovery time along with acce |
242) r refractory cancers harboring DNA damage response and repair alterations, including |
|